These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 7948733

  • 21. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E, Tóth G, Benyhe S, Tourwe D, Péter A, Tömböly C, Borsodi A.
    Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
    [Abstract] [Full Text] [Related]

  • 22. Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid.
    Ciajolo MR, Balboni G, Picone D, Salvadori S, Tancredi T, Temussi PA, Tuzi A.
    Int J Pept Protein Res; 1995 Aug; 46(2):134-8. PubMed ID: 8567167
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A comprehensive study on the putative δ-opioid receptor (sub)types using the highly selective δ-antagonist, Tyr-Tic-(2S,3R)-β-MePhe-Phe-OH.
    Birkas E, Bakota L, Gulya K, Wen T, Pintar J, Tóth G, Szucs M.
    Neurochem Int; 2011 Aug; 59(2):192-201. PubMed ID: 21672586
    [Abstract] [Full Text] [Related]

  • 25. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
    Schiller PW, Fundytus ME, Merovitz L, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Coderre TJ.
    J Med Chem; 1999 Sep 09; 42(18):3520-6. PubMed ID: 10479285
    [Abstract] [Full Text] [Related]

  • 26. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov 09; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

  • 27. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G, Ioja E, Tömböly C, Ballet S, Tourwé D, Péter A, Martinek T, Chung NN, Schiller PW, Benyhe S, Borsodi A.
    J Med Chem; 2007 Jan 25; 50(2):328-33. PubMed ID: 17228874
    [Abstract] [Full Text] [Related]

  • 28. Conversion of enkephalin and dermorphin into delta-selective opioid antagonists by single-residue substitution.
    Tancredi T, Salvadori S, Amodeo P, Picone D, Lazarus LH, Bryant SD, Guerrini R, Marzola G, Temussi PA.
    Eur J Biochem; 1994 Aug 15; 224(1):241-7. PubMed ID: 8076645
    [Abstract] [Full Text] [Related]

  • 29. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
    Segawa M, Ohno Y, Doi M, Inoue M, Ishida T, Iwashita T.
    Int J Pept Protein Res; 1994 Sep 15; 44(3):295-304. PubMed ID: 7822107
    [Abstract] [Full Text] [Related]

  • 30. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.
    Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN, Lemieux C.
    J Med Chem; 1993 Oct 15; 36(21):3182-7. PubMed ID: 8230106
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
    Balboni G, Guerrini R, Salvadori S, Bianchi C, Rizzi D, Bryant SD, Lazarus LH.
    J Med Chem; 2002 Jan 31; 45(3):713-20. PubMed ID: 11806723
    [Abstract] [Full Text] [Related]

  • 32. The delta-selective opioid peptide dermenkephalin and the mu-selective hybrid peptide dermenkephalin-[1-4]-dermophin-[5-7] display strikingly different conformations despite identical tetrapeptide N-termini. A quantitative 2-D NMR and molecular modeling analysis.
    Riand J, Baron D, Nicolas P, Benajiba A, Teng Y, Naim M.
    J Biomol Struct Dyn; 1999 Dec 31; 17(3):445-60. PubMed ID: 10636080
    [Abstract] [Full Text] [Related]

  • 33. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.
    Brandt W, Stoldt M, Schinke H.
    J Comput Aided Mol Des; 1996 Jun 31; 10(3):201-12. PubMed ID: 8808737
    [Abstract] [Full Text] [Related]

  • 34. Influence of sample pH on the conformational backbone dynamics of a pseudotripeptide (H-Tyr-Tic psi [CH2-NH]Phe-OH) incorporating a reduced peptide bond: an NMR investigation.
    Carpenter KA, Wilkes BC, Schiller PW.
    Biopolymers; 1995 Dec 31; 36(6):735-49. PubMed ID: 8555421
    [Abstract] [Full Text] [Related]

  • 35. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL, Schmitter SJ, Bouzit H, Johnson TW, Hepp AM, Kurtz KR, Mousigian C.
    Int J Pept Protein Res; 1994 Nov 31; 44(5):420-6. PubMed ID: 7896499
    [Abstract] [Full Text] [Related]

  • 36. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
    Schmidt R, Kálmán A, Chung NN, Lemieux C, Horváth C, Schiller PW.
    Int J Pept Protein Res; 1995 Jul 31; 46(1):47-55. PubMed ID: 7558596
    [Abstract] [Full Text] [Related]

  • 37. Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.
    Bryant SD, George C, Flippen-Anderson JL, Deschamps JR, Salvadori S, Balboni G, Guerrini R, Lazarus LH.
    J Med Chem; 2002 Dec 05; 45(25):5506-13. PubMed ID: 12459018
    [Abstract] [Full Text] [Related]

  • 38. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K, Varga EV, Alfaro-Lopez J, Tang X, Vanderah TW, Porreca F, Hruby VJ, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 2003 Feb 05; 304(2):683-8. PubMed ID: 12538822
    [Abstract] [Full Text] [Related]

  • 39. From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.
    Balboni G, Cocco MT, Salvadori S, Romagnoli R, Sasaki Y, Okada Y, Bryant SD, Jinsmaa Y, Lazarus LH.
    J Med Chem; 2005 Aug 25; 48(17):5608-11. PubMed ID: 16107162
    [Abstract] [Full Text] [Related]

  • 40. Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands.
    Kumar V, Murray TF, Aldrich JV.
    J Med Chem; 2000 Dec 28; 43(26):5050-4. PubMed ID: 11150177
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.